The Role of Intravenous Vasodilators in Acute Heart Failure Management

被引：21

作者：

Piper, Susan ^{[1
]}

McDonagh, Theresa ^{[1
]}

机构：

[1] Kings Coll London, Dept Cardiovasc Res, London WC2R 2LS, England

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷 / 08期

关键词：

Acute heart failure; Vasodilators; Nitrates; BRAIN NATRIURETIC PEPTIDE; SEVERE PULMONARY-EDEMA; QUALITY-OF-CARE; ISOSORBIDE-DINITRATE; NITRATE TOLERANCE; DOUBLE-BLIND; MYOCARDIAL-INFARCTION; CONTROLLED TRIAL; SURVEY PROGRAM; TASK-FORCE;

D O I：

10.1002/ejhf.123

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute heart failure is a major cause of emergency hospital admission, with significant impact on health resources and patient outcomes. With no new treatments for over 20 years, the advent of new innovative therapies may facilitate a radical change in our approach to such patients. In this article, we examine the current evidence for the use of current intravenous vasodilators in AHF management, and review the potential of novel therapies currently in development.

引用

页码：827 / 834

页数：8

共 59 条

[1]

Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1

[2] Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].

Adams, KF ;

Fonarow, GC ;

Emerman, CL ;

LeJemtel, TH ;

Costanzo, MR ;

Abraham, WT ;

Berkowitz, RL ;

Galvao, M ;

Horton, DP .

AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216

[3]

[Anonymous], 2014, SAF TOL SER ADD STAN

[4]

Beltrame J F, 1998, J Card Fail, V4, P271, DOI 10.1016/S1071-9164(98)90232-9

[5] What are the costs of heart failure? [J].

Braunschweig, Frieder ;

Cowie, Martin R. ;

Auricchio, Angelo .

EUROPACE, 2011, 13 :II13-II17

[6] Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study [J].

Breidthardt, T. ;

Noveanu, M. ;

Potocki, M. ;

Reichlin, T. ;

Egli, P. ;

Hartwiger, S. ;

Socrates, T. ;

Gayat, E. ;

Christ, M. ;

Mebazaa, A. ;

Mueller, C. .

JOURNAL OF INTERNAL MEDICINE, 2010, 267 (03) :322-330

[7] The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].

Cleland, JGF ;

Swedberg, K ;

Follath, F ;

Komajda, M ;

Cohen-Solal, A ;

Aguilar, JC ;

Dietz, R ;

Gavazzi, A ;

Hobbs, R ;

Korewicki, J ;

Madeira, HC ;

Moiseyev, VS ;

Preda, I ;

van Gilst, WH ;

Widimsky, J ;

Freemantle, N ;

Eastaugh, J ;

Mason, J .

EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463

[8] The heart failure epidemic: exactly how big is it? [J].

Cleland, JGF ;

Khand, A ;

Clark, A .

EUROPEAN HEART JOURNAL, 2001, 22 (08) :623-626

[9] The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure [J].

Cotter, G ;

Moshkovitz, Y ;

Kaluski, E ;

Milo, O ;

Nobikov, Y ;

Schneeweiss, A ;

Krakover, R ;

Vered, Z .

EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (04) :443-451

[10] Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema [J].

Cotter, G ;

Metzkor, E ;

Kaluski, E ;

Faigenberg, Z ;

Miller, R ;

Simovitz, A ;

Shaham, O ;

Marghitay, D ;

Koren, M ;

Blatt, A ;

Moshkovitz, Y ;

Zaidenstein, R ;

Golik, A .

LANCET, 1998, 351 (9100) :389-393

← 1 2 3 4 5 6 →